COVID-19-positive patients had significantly elevated IgA, IgG and IgG-subclass response towards the SARS-CoV-2-specific full-length and truncated proteins (Figure 1C and Supplementary Figures S2–S4). This evidence concerns the gene CD79A and COVID-19.